Transcriptional regulation of COX‐2: a key mechanism in the pathogenesis of nasal polyposis in aspirin‐sensitive asthmatics?
Open Access
- 1 February 2003
- Vol. 58 (2) , 95-97
- https://doi.org/10.1034/j.1398-9995.2003.00103.x
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Nuclear Factor‐Kappa B Activation in the Nasal Polyp Epithelium: Relationship to Local Cytokine Gene ExpressionThe Laryngoscope, 2002
- Safety of a specific COX‐2 inhibitor in aspirin‐induced asthmaClinical and Experimental Allergy, 2001
- Aspirin-induced rhinitis and asthmaCurrent Opinion in Allergy and Clinical Immunology, 2001
- Differential Metabolism of Arachidonic Acid in Nasal Polyp Epithelial Cells Cultured from Aspirin-sensitive and Aspirin-tolerant PatientsAmerican Journal of Respiratory and Critical Care Medicine, 2000
- The NF-κB Activation Pathway: A Paradigm in Information Transfer from Membrane to NucleusScience's STKE, 1999
- Allergic lung responses are increased in prostaglandin H synthase–deficient miceJournal of Clinical Investigation, 1999
- Cyclooxygenase-2 mRNA Is Downexpressed in Nasal Polyps from Aspirin-sensitive AsthmaticsAmerican Journal of Respiratory and Critical Care Medicine, 1999
- Role of transcription factors in inflammatory lung diseasesThorax, 1998
- Prostaglandin E2 and aspirin-induced asthmaThe Lancet, 1995
- Function and Activation of NF-Kappa B in the Immune SystemAnnual Review of Immunology, 1994